Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-810-4 | CAS number: 68915-38-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes
- Remarks:
- BASF AG, Experimental Toxicology and Ecology
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Cyclohexane, oxidized, aquous extract
- IUPAC Name:
- Cyclohexane, oxidized, aquous extract
- Reference substance name:
- Cyclohexane, oxidized, aq. ext.
- EC Number:
- 272-810-4
- EC Name:
- Cyclohexane, oxidized, aq. ext.
- Cas Number:
- 68915-38-8
- Molecular formula:
- not available
- IUPAC Name:
- Cyclohexane, oxidized, aq. ext.
- Details on test material:
- - Name of test material (as cited in study report): Dicarbonsaeure Loesung peroxidfrei EP306/Acid Water
- Analytical purity: Aqueous formulation, content of active ingredient: Residue on drying: 41.8 g/100 g
- Stability under test conditions: The stability of the test item will be verified by reanalysis on completion of exposure/administration or in some other way.
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Sulzfeld
- Age at study initiation: 8 – 12 weeks
- Weight at study initiation: 16.4 g – 23.2 g
- Housing: single
- Diet (e.g. ad libitum): Kliba-Labordiet
- Water (e.g. ad libitum): Tap water
- Acclimation period: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- other: 1% Pluronic L 92 Surfactant
- Concentration:
- Undiluted test item with addition of 1% Pluronic (99+1)
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- pretest with the undiluted test item with addition of 1% Pluronic L92 were considered, which showed slightly increased lymph node weights and ear weights as indication of ear irritation. Additionally, the pretest showed the feasibility of applying the undiluted test item without producing any toxic effects compromising the outcome of a full study.
TREATMENT PREPARATION AND ADMINISTRATION:
- Test-item preparation and homogenization until end of each application period: The mixture of the undiluted test item + 1% Pluronic (99+1) was produced on a weight per weight basis shortly before the application by stirring with a magnetic stirrer. The homogeneity during application was provided by stirring with a magnetic stirrer.
- Vehicle: 1% Pluronic L 92 Surfactant in highly de-ionized water (control group) and 1% Pluronic L 92 Surfactant (test group)
- Reason for the vehicle: The test item itself is an aqueous preparation. By means of the surface-active agent Pluronic L 92 a run off of the test-item was prevented.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- The study used 1 test group and 1 control group. Each test animal was applied with 25 µL per ear of the test-item preparation to the dorsum of both ears for three consecutive days. The control group was treated with 25 µL per ear of the vehicle alone.
- No detailed clinical examination of the individual animals was performed but any obvious signs of systemic toxicity and/or local inflammation at the application sites were noted.
- Three days after the last application the mice were injected intravenously with 20 µCi of 3H-thymidine in 250 µL of sterile saline into a tail vein. About 5 hours after the 3H-thymidine injection, the mice were sacrificed and the auricular lymph nodes were removed. The weights of each animal’s pooled lymph nodes were determined. Thereafter lymph nodes were pooled group wise and further evaluated by measuring their cellular content and 3H-thymidine incorporation into the lymph node cells (indicators of cell proliferation). Moreover, a defined area with a diameter of 0.8 cm was punched out of the apical part of each ear and for each test group the weight of the pooled punches was determined in order to obtain an indication of possible skin irritation.
- Calculations: The stimulation indices of cell count, 3H-thymidine incorporation, lymph node weight and ear weight were calculated as the ratio of the test group values for these parameters divided by those of the vehicle control group.
- Criteria used to consider a positive response: The parameters used to characterize the response are lymph node cell count, 3H-thymidine incorporation into the lymph node cells and to a certain extent lymph node weight. Because not only sensitization induction but also irritation of the ear skin by the test item may induce lymph node responses, the weight of ear punches taken from the area of test-item application is determined as a parameter for inflammatory ear swelling serving as an indicator for the irritant action of the test item. The increase SI of cell count by a factor of = 1.5 and/or of 3H-thymidine incorporation by a factor of = 3 as compared to the concurrent vehicle control group is generally considered as indicating a sensitizing potential of a test item. - Positive control substance(s):
- other: see free text
Results and discussion
In vivo (LLNA)
Results
- Parameter:
- SI
- Remarks on result:
- other: see free text
Any other information on results incl. tables
The stimulation indices (fold of change as compared to the vehicle control) for cell count, 3H-thymidine incorporation, lymph node weight and ear weight are summarized for each test group in the table below.
Treatment |
Cell Count SI |
3H-thymidine incorporation SI |
Lymph Node weight SI |
Ear weight SI |
vehicle 1% aqueous Pluronic |
1.00 |
1.00 |
1.00 |
1.00 |
test item + Pluronic (99+1) * |
1.33 |
2.47 |
1.24 |
1.19 |
* Calculation on basis of 4 animals, as one animal died during 3H-thymidine injection.
- No signs of systemic toxicity were noticed.
- The undiluted test item with addition of 1% Pluronic did not induce a biologically relevant response (no increase to 1.5 fold or above of control value = stimulation index (SI) = 1.5) in the auricular lymph node cell counts.
- There was no relevant increase in lymph node weights, as well.
- Concomitantly, the increase of 3H-thymidine incorporation into the cells was not biologically relevant (no increase above the cut off stimulation index of 3).
- The undiluted test item with addition of 1% Pluronic caused some increase in ear weights as indication of ear skin irritation. Scaling on the ears was observed in all animals on the day of lymph node removal
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- It is concluded that the test substance does not show a skin sensitizing effect in the Murine Local Lymph Node Assay under the test conditions chosen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.